278 related articles for article (PubMed ID: 23542781)
1. DAXX silencing suppresses mouse ovarian surface epithelial cell growth by inducing senescence and DNA damage.
Pan WW; Yi FP; Cao LX; Liu XM; Shen ZF; Bu YQ; Xu Y; Fan HY; Song FZ
Gene; 2013 Sep; 526(2):287-94. PubMed ID: 23542781
[TBL] [Abstract][Full Text] [Related]
2. Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.
Pan WW; Zhou JJ; Liu XM; Xu Y; Guo LJ; Yu C; Shi QH; Fan HY
J Biol Chem; 2013 May; 288(19):13620-30. PubMed ID: 23539629
[TBL] [Abstract][Full Text] [Related]
3. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
4. Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres.
Salsman J; Rapkin LM; Margam NN; Duncan R; Bazett-Jones DP; Dellaire G
Cell Death Dis; 2017 Mar; 8(3):e2724. PubMed ID: 28358373
[TBL] [Abstract][Full Text] [Related]
5. Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation.
Muromoto R; Ishida M; Sugiyama K; Sekine Y; Oritani K; Shimoda K; Matsuda T
J Immunol; 2006 Jul; 177(2):1160-70. PubMed ID: 16818774
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx.
Zhao LY; Colosimo AL; Liu Y; Wan Y; Liao D
J Virol; 2003 Nov; 77(21):11809-21. PubMed ID: 14557665
[TBL] [Abstract][Full Text] [Related]
7. HSV-1 genome subnuclear positioning and associations with host-cell PML-NBs and centromeres regulate LAT locus transcription during latency in neurons.
Catez F; Picard C; Held K; Gross S; Rousseau A; Theil D; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2012; 8(8):e1002852. PubMed ID: 22912575
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
Lehembre F; Müller S; Pandolfi PP; Dejean A
Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
[TBL] [Abstract][Full Text] [Related]
9. DAXX promotes ovarian cancer ascites cell proliferation and migration by activating the ERK signaling pathway.
Liu SB; Lin XP; Xu Y; Shen ZF; Pan WW
J Ovarian Res; 2018 Oct; 11(1):90. PubMed ID: 30336783
[TBL] [Abstract][Full Text] [Related]
10. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.
Li H; Leo C; Zhu J; Wu X; O'Neil J; Park EJ; Chen JD
Mol Cell Biol; 2000 Mar; 20(5):1784-96. PubMed ID: 10669754
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by sequestering Daxx to the PML oncogenic domains (PODs) to enhance its transactivation potential.
Lin DY; Lai MZ; Ann DK; Shih HM
J Biol Chem; 2003 May; 278(18):15958-65. PubMed ID: 12595526
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.
Ho CL; Huang YC; Tai CK; Liu ST; Wang JK; Wang WM; Huang SM
Int J Biochem Cell Biol; 2010 Jun; 42(6):902-10. PubMed ID: 20097304
[TBL] [Abstract][Full Text] [Related]
13. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
[TBL] [Abstract][Full Text] [Related]
14. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.
Zhong S; Salomoni P; Ronchetti S; Guo A; Ruggero D; Pandolfi PP
J Exp Med; 2000 Feb; 191(4):631-40. PubMed ID: 10684855
[TBL] [Abstract][Full Text] [Related]
15. Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.
Song H; Boo JH; Kim KH; Kim C; Kim YE; Ahn JH; Jeon GS; Ryu H; Kang DE; Mook-Jung I
Cell Death Differ; 2013 Apr; 20(4):639-48. PubMed ID: 23306558
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
[TBL] [Abstract][Full Text] [Related]
17. Role of nuclear bodies in apoptosis signalling.
Krieghoff-Henning E; Hofmann TG
Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
[TBL] [Abstract][Full Text] [Related]
18. MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.
Peche LY; Scolz M; Ladelfa MF; Monte M; Schneider C
Cell Death Differ; 2012 Jun; 19(6):926-36. PubMed ID: 22117195
[TBL] [Abstract][Full Text] [Related]
19. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
20. PML links aberrant cytokine signaling and oncogenic stress to cellular senescence.
Bourdeau V; Baudry D; Ferbeyre G
Front Biosci (Landmark Ed); 2009 Jan; 14(2):475-85. PubMed ID: 19273079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]